Current approaches to management of cerebral fungal infection in pediatric patients with hematologic disorders

Journal of Pediatric Hematology/Oncology

Volumn 30, Issue 3, 2008, Pages 249-253

  Sato, Tomonobu ^a,b   Kaneda, Makoto ^a   Ichikawa, Mizuho ^a   Suzuki, Daisuke ^a   Nakagawa, Atsuko ^c   Kobayashi, Ryoji ^a,b  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b SAPPORO HOKUYU HOSPITAL   (Japan)

^c NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

Aspergillus; Brain abscess; Fungal infection; Mucormycosis

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; DIURETIC AGENT; DOPAMINE; ETOPOSIDE; FLUCONAZOLE; FLUCYTOSINE; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; ITRACONAZOLE; LYMPHOCYTE ANTIBODY; METHOTREXATE; MICAFUNGIN; MITOXANTRONE; OXYGEN; VORICONAZOLE;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; ALLOGENIC BONE MARROW TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; ARTIFICIAL VENTILATION; ASPERGILLUS; ASSISTED VENTILATION; AUTOPSY; BONE MARROW BIOPSY; BRAIN ABSCESS; BRAIN SURGERY; CANCER COMBINATION CHEMOTHERAPY; CANDIDA; CASE REPORT; CAUSE OF DEATH; CENTRAL VENOUS CATHETER; CENTRAL VENOUS CATHETERIZATION; COMPUTER ASSISTED TOMOGRAPHY; CRANIOTOMY; DONOR; DRUG FEVER; FEMALE; FOCAL EPILEPSY; FUNGAL DETECTION; GRAFT FAILURE; HEART FAILURE; HEMATOLOGIC DISEASE; HEMIPLEGIA; HISTOPATHOLOGIC SKIN REACTION; HISTOPATHOLOGY; HUMAN; HYPOXEMIA; IMMUNOSUPPRESSIVE TREATMENT; INFECTION PREVENTION; LUNG ASPERGILLOSIS; LUNG INFILTRATE; LUNG LAVAGE; LUNG MYCOSIS; MALE; MUCORMYCOSIS; MYCOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN THERAPY; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PLEURA EFFUSION; PNEUMOCYSTIS JIROVECI; PRIORITY JOURNAL; REMISSION; SCHOOL CHILD; TACHYPNEA; THORAX RADIOGRAPHY; URINE VOLUME; WHOLE BODY RADIATION;

ADOLESCENT; AMPHOTERICIN B; ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; ASPERGILLOSIS; CENTRAL NERVOUS SYSTEM FUNGAL INFECTIONS; CHILD; DRUG COMBINATIONS; ECHINOCANDINS; FATAL OUTCOME; FEMALE; FLUCYTOSINE; FOLLOW-UP STUDIES; GRAFT REJECTION; HEMATOLOGIC DISEASES; HUMANS; LEUKEMIA, MYELOID, ACUTE; LIPOPROTEINS; MAGNETIC RESONANCE IMAGING; MALE; MUCORMYCOSIS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; REMISSION INDUCTION; TREATMENT OUTCOME;

EID: 41849109540     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e318161aa0c     Document Type: Article

References (19)

1. Gold JW. Opportunistic fungal infections in patients with neoplastic disease. Am J Med. 1984;76:458-463.
2. Donnelly JP. Symptoms and diagnosis of nosocomial fungal infections - state-of-the-art. Eur J Med Res. 2003;7:192-199.
3. Erjavec Z, Verweij PE. Recent progress in the diagnosis of fungal infections in the immunocompromised host. Drug Resist Updat. 2002;5:3-10.
4. Colombo AL, Rosas RC. Successful treatment of an Aspergillus brain abscess with caspofungin: case report of a Diabetic Patient Intolerant of Amphotericin B. Eur J Clin Microbiol Infect Dis. 2003;22:575-576.
5. Satoh H, Uozumi T, Kiya K, et al. Invasive aspergilloma of the frontal base causing internal carotid artery occlusion. Surg Neurol. 1995;44:483-488.
6. Warnock DW. Fungal infections in neutropenia: current problems and chemotherapeutic control. J Antimicrob Chemother. 1998;41:95-105.
7. Roden MM, Zaoutis TE, Buchanan WL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005;41:634-653.
8. Parfrey NA. Improved diagnosis and prognosis of mucormycosis. A clinico-pathologic study of 33 cases. Medicine (Baltimore). 1986;65:113-123.
9. Jessica AW, Scott MB, Julie RP, et al. Prolonged survival after invasive aspergillosis: a Single-Institution Review of 11 Cases. J Ped Hematol Oncol. 2003;25:286-291.
10. Denning DW. Invasive aspergillosis. Clin Infect Dis. 1998;26:781-803.
11. Schwartz S, Thiel E. Update on the treatment of cerebral aspergillosis. Ann Hematol. 2004;83(suppl 1):S42-S44.
12. Stevens DA, Kan VL, Judson MA, et al. Practice guidelines for diseases caused by Aspergillus. Clin Infect Dis. 2000;30:696-697.
13. Schwartz S, Milatovic D, Thiel E. Successful treatment of cerebral aspergillosis with a novel triazole (voriconazole) in a patient with acute leukaemia. British J Haematol. 1997;97:663-665.
14. Groll AH, Giri N, Petraitis V, et al. Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous system. J Infect Dis. 2000;182:274-282.
15. Cornely OA, Maertens J, Bresnik M, et al. Liposomal amphotericin B as initial therapy invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial). Clin Infect Dis. 2007;44:1289-1297.
16. Kontonyiannis DP, Wessel VC, Bodey GP, et al. Zygomycosis in the 1990's in a tertiary-care cancer center. Clin Infect Dis. 2000;30:851-856.
17. Goetz W, Wolfgang H, Gabriele K, et al. Rhinocerebral mucormycosis in a boy with recurrent acute lymphoblastic leukemia: Long-term survival with systemic antifungal treatment. J Ped Hematol Oncol. 2002;24:492-494.
18. Blitzer A, Lawson W, Meyers B, et al. Patient survival in paranasal mucormycosis. Laryngoscope. 1980;90:635-648.
19. Trifilio SM, Bennett CL, Yarnold PR, et al. Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy. Bone Marrow Transplant. 2007;39:425-429.